In our previous article, we highlighted the three different themes, which will taka place during the 12th BIOVISION Forum in Lyon from the 4th to the 6th April 2017. BIOVISION Prospective, BIOVISION Catalyser and the BIOVISION Investor. This article will mainly focus on BIOVISION Prospective, which is a meeting place for stakeholders in global health leading to ONE HEALTH.
What do partners benefit from participating in the BIOVISION Forum?
Listen to this Mr. Peter Sun from Shenzhen Beike Bio-Technology – China
What is ONE HEALTH?
ONE HEALTH is “the collaborative effort of multiple disciplines – working locally, nationally, and globally – to attain optimal health for people, animals and the environment” and it will be the main topic for Biovision Prospective.
Biovision Prospective will be divided in 6 paths where an exchange time, bridge meetings between 20 experts and challengers chosen amongst attendees, insights and a delivery of the call for action will take place.
Each path, will have a sub-theme. Global medical education & training, Digital health and innovation for sustainable healthcare, Emerging viral diseases, Animal health, Cancer, Innovative technologies and science of metagenomics to reach ONE HEALTH.
The Prospective meetings will facilitate discussions between Biovision participants, international experts and leading figures in global health and prevention throughout the course of four main session focusing on the following paths:
- Global medical education & training
- Digital health and innovation for sustainable healthcare
- Emerging viral diseases
- Animal health
- Innovative technologies and science of metagenomics to reach ONE HEALTH
During each session, twenty to thirty experts will participate and exchange ideas in workshops. Their conclusions will be presented at plenary session and finalized within the Call for action addressed to the international community at Biovision’s closing ceremony.
For more information: